tetano
Editor, Senior Moderator
J Med Virol
. 2023 Sep;95(9):e29053.
doi: 10.1002/jmv.29053. Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine
Soumya Sengupta[SUP] 1 2 3 [/SUP], Shubham K Shaw[SUP] 1 2 3 [/SUP], Sanchari Chatterjee[SUP] 1 2 4 [/SUP], Gargee Bhattacharya[SUP] 1 2 3 [/SUP], Prakash K Barik[SUP] 1 3 [/SUP], Soma Chattopadhyay[SUP] 1 2 4 [/SUP], Satish Devadas[SUP] 1 2 3 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection has caused an increase in mortality and morbidity, but with vaccination, the disease severity has significantly reduced. With the emergence of various variants of concern (VOCs), the vaccine breakthrough infection has also increased. Here we studied circulating spike-specific T follicular response (cTfh) in infection-naïve vaccinees and convalescent vaccinees (individuals who got the Delta breakthrough infection after two doses of BBV152 vaccine) to understand their response as they are the most crucial cells that are involved in vaccine-mediated protection by helping in B-cell maturation. Our results indicated that cTfh cells in both the groups recognized the wild-type and Delta spike protein but memory response to the wild-type spike was superior in infection-naïve than in the convalescent group. The cytokine response, particularly interleukin-21 (IL-21) from cTfh, was also higher in infection-naïve than in convalescent vaccinees, indicating a dampened cTfh response in convalescent vaccinees after breakthrough infection. Also, there was a positive correlation between IL-21 from cTfh cells and neutralizing antibodies of infection-naïve vaccinees. Multiple cytokine analysis also revealed higher inflammation in convalescent vaccinees. Our data indicated that the necessity of a third booster dose may be individual-specific depending on the steady-state functional phenotype of immune cells.
Keywords: SARS-CoV2 viral variants; T follicular cells; adaptive immune response; inactivated vaccines; neutralizing antibodies.
. 2023 Sep;95(9):e29053.
doi: 10.1002/jmv.29053. Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine
Soumya Sengupta[SUP] 1 2 3 [/SUP], Shubham K Shaw[SUP] 1 2 3 [/SUP], Sanchari Chatterjee[SUP] 1 2 4 [/SUP], Gargee Bhattacharya[SUP] 1 2 3 [/SUP], Prakash K Barik[SUP] 1 3 [/SUP], Soma Chattopadhyay[SUP] 1 2 4 [/SUP], Satish Devadas[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 37650214
- DOI: 10.1002/jmv.29053
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection has caused an increase in mortality and morbidity, but with vaccination, the disease severity has significantly reduced. With the emergence of various variants of concern (VOCs), the vaccine breakthrough infection has also increased. Here we studied circulating spike-specific T follicular response (cTfh) in infection-naïve vaccinees and convalescent vaccinees (individuals who got the Delta breakthrough infection after two doses of BBV152 vaccine) to understand their response as they are the most crucial cells that are involved in vaccine-mediated protection by helping in B-cell maturation. Our results indicated that cTfh cells in both the groups recognized the wild-type and Delta spike protein but memory response to the wild-type spike was superior in infection-naïve than in the convalescent group. The cytokine response, particularly interleukin-21 (IL-21) from cTfh, was also higher in infection-naïve than in convalescent vaccinees, indicating a dampened cTfh response in convalescent vaccinees after breakthrough infection. Also, there was a positive correlation between IL-21 from cTfh cells and neutralizing antibodies of infection-naïve vaccinees. Multiple cytokine analysis also revealed higher inflammation in convalescent vaccinees. Our data indicated that the necessity of a third booster dose may be individual-specific depending on the steady-state functional phenotype of immune cells.
Keywords: SARS-CoV2 viral variants; T follicular cells; adaptive immune response; inactivated vaccines; neutralizing antibodies.